Brighthouse Financial (BHF) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
7 Jan, 2026Executive summary
A special meeting is scheduled for February 12, 2026, for shareholders to vote on a proposed merger in which Aquarian Holdings VI L.P. will acquire all outstanding common stock of Brighthouse Financial for $70.00 per share in cash, representing a 37% premium to the unaffected share price prior to the merger announcement.
The board unanimously recommends voting in favor of the merger, citing a robust sale process, premium to market price, certainty of value, and favorable terms and conditions in the merger agreement.
The merger is subject to customary closing conditions, including regulatory approvals from insurance regulators in Delaware, Massachusetts, and New York, antitrust clearance, and approval by a majority of outstanding common stockholders.
If approved, Brighthouse Financial will become a wholly owned subsidiary of Aquarian Holdings, and its common stock will be delisted from Nasdaq.
Voting matters and shareholder proposals
Shareholders will vote on three proposals: (1) approval of the merger agreement, (2) an advisory vote on compensation for named executive officers related to the merger, and (3) adjournment of the meeting if more time is needed to solicit votes.
Approval of the merger requires a majority of outstanding shares; abstentions and failures to vote count as votes against.
The board recommends voting FOR all proposals.
Board of directors and corporate governance
The board conducted a comprehensive review of strategic alternatives, engaged financial and legal advisors, and oversaw a competitive sale process involving multiple bidders.
The board considered the interests of shareholders, the fairness of the offer, and the likelihood of closing when making its recommendation.
The merger agreement allows the board to consider superior proposals and, under certain conditions, to change its recommendation.
Latest events from Brighthouse Financial
- Q4 net income declined, but record annuity and life sales and a pending $4.1B acquisition marked 2025.BHF
Q4 202523 Feb 2026 - Merger and related proposals were approved by stockholders as recommended by the board.BHF
EGM 202612 Feb 2026 - Shareholders to vote on merger amid litigation and board's unanimous support.BHF
Proxy Filing4 Feb 2026 - Adjusted earnings reached $346M with record life sales, but statutory capital and RBC ratio declined.BHF
Q2 20242 Feb 2026 - Adjusted earnings surged on actuarial gains, with life sales up 19% and capital actions ongoing.BHF
Q3 202415 Jan 2026 - Q4 2024 net income was $646M, with record annuity and life sales and strong capital metrics.BHF
Q4 202426 Dec 2025 - Shareholders to vote on $70.00 per share cash merger, with board unanimous in recommending approval.BHF
Proxy Filing23 Dec 2025 - Preliminary proxy outlines annual meeting proposals and board governance for shareholder vote.BHF
Proxy Filing1 Dec 2025 - Shareholders to vote on directors, auditor, executive pay, and updated incentive plan amid strong strategic progress.BHF
Proxy Filing1 Dec 2025